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ABSTRACT
Seven male dogs with clinically and histologically conﬁ rmed mammary gland tumours were included 
in this study. All dogs were sexually intact. Median age at diagnosis was 9.4 yrs. Five were purebred and the 
rest were mongrels. Six dogs had a solitary growth whereas in one animal multiple growths were seen. All 
tumours were histologically benign. Simple adenomas with mixed acinar and papillary pattern were observed. 
All tumours were removed surgically. Healing was perfect in all cases without any postoperative complications. 
No recurrence was recorded up to six months post-surgery. The expression of sex hormones and p53, cox-2 and 
MMP-7 tumour marker genes was strong in the majority of cases. Although uncommon, mammary tumours do 
occur in male dogs.
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Introduction 
Cancer has gained considerable relevance in animals recently owing to the increased 
awareness among people of animal suffering and pain. The diagnosis and management 
of neoplasms, therefore, represents a major challenge faced by veterinary oncologists. 
Mammary gland tumours are among the most common canine neoplasms, but the vast 
majority of these tumours occur in intact female dogs (BRODEY et al., 1983; KHIMTA et 
al., 2010). In canines, mammary gland tumours that occur in males range from 0-2.7% 
(average <1%) (MOULTON et al., 1970). Sex hormones play a vital role in the occurrence 
of mammary gland tumours. The p53 gene over expression is an independent factor 
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indicating worse prognosis in canine mammary gland tumours (LEE et al., 2004). The p53 
may be a useful prognostic marker for evaluating malignancy in canine mammary gland 
tumours (ILHAN et al., 2008). There is a strong positive correlation between expression 
of cyclooxygenase-2 (cox-2) and the grade of malignancy in the tumour. Increased cox-2 
expression is linearly related to worse prognosis and shorter overall survival of the canine 
mammary gland tumour patients. Canine mammary gland malignant tumours had the 
highest values of cox-2 expression (QUEIROGA et al., 2007). Matrix metalloproteinase 
(MMPs) is a family of zinc and calcium-dependent proteolytic enzymes that degrade 
macromolecules of the extracellular matrix. Members of this family, such as MMP-2, 
-9 and -7, have been shown to be associated with tumour progression and invasion in 
human cancer tissues. Matrilysin (MMP-7) inﬂ uences the early stage of tumourigenesis 
(NELSON et al., 2000). 
Reports of mammary gland tumours in male dogs are lacking. In this study, seven 
mammary gland tumours in male dogs are presented.
Materials and methods
The study was carried out on seven male dogs of different breeds and ages, with 
variable sizes of spontaneous mammary gland tumours, which presented at the Institute’s 
Referral Veterinary Polyclinic. Details of these cases are given in Table 1.
Table 1. Animal case history







1 Dog Germanshepherd 10
Intact
male
Tumour at level of 
prepuce
(9 cm in diameter)
Simple adenoma 
(papillary)
2 Dog Spitz 8 -do-
Tumour at 
right of prepuce
(5 cm in diameter)
Simple adenoma
(acinar)
3 Dog Germanshepherd 11 -do-
Tumour at
right of prepuce
( 7 cm in diameter)
Simple adenoma
(acinar)
4 Dog Mongrel 9 -do-
Tumour at
left abdominal
(9 cm in diameter)
Complex adenoma
(acinar)
5 Dog Doberman 10 -do-
Tumour at
level of prepuce
( 8 cm in diameter)
Simple adenoma
(acinar)
6 Dog CockerSpaniel 7 -do-
Tumour at
left of prepuce
(7.5 cm in diameter)
Papillary 
fibroadenoma
7 Dog Mongrel 11 -do- Tumour at left caudal( 6 cm in diameter)
Simple adenoma
(papillary)
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Thoracic radiographs were taken in all these patients to detect the possible presence 
of lung metastasis. Tumour biopsy samples were collected before any therapy, ﬁ xed 
immediately in 10% neutral buffered formalin and processed routinely by parafﬁ n 
embedding technique. Sections of 4-5 microns thickness were cut and stained by 
haematoxylin and eosin (H&E) for histopathological examination.
The levels of oestrogen and progesterone were estimated in serum samples with 
radio-immune assay (RIA) kit (Immunotech SAS-130 France). Samples and calibrators 
were incubated for 3 hours with 125, I-labelled estradiol, as tracer, in antibody coated 
tubes. After incubation, the content of the tubes was aspirated, and bound radioactivity 
was measured. A calibration curve was established and unknown values were determined 
by interpolation from the curve.
The expression of enzyme matrilysin/MMP-7 (matrix metalloproteinase) genes was 
assessed after collecting the tumour tissues from the affected male animal, as well as 
from ﬁ ve adult non-descript breeds of normal (CMT unaffected) male dogs by gelatine 
zymography and RT-PCR. The necessary permission was obtained from the animal’s 
owner, as well as from the Institute’s Animal Ethics Committee for collection of normal 
mammary tissue from the same location of the mammary glands in male animals. 
For gelatine zymography, homogenized tumour tissue was prepared using a REMI 
homogenizer, and the crude extract was mixed with 5X sample/gel loading buffer in a 5:1 
ratio, and loaded into the wells of gel casting, ﬁ xed into vertical slab, gel electrophoresis 
apparatus. Electrophoresis was carried out at room temperature with constant voltage 
mode at 100 V. This was followed by incubation of the gel in 2.5% Triton X - 100 solutions 
at room temperature for 3 hours, and later in developing buffer at 37 ºC for 18 hours. 
Following this the gel was stained with 0.25% coomassie blue for 2 hours and destained 
in deionized water. RT-PCR for MMP-7 gene expression was carried out with the gene 
speciﬁ c primer namely F: 5’- GATGTGGTGTGCCTGATGTC-3’ and R: 5’-CTCCTCT 
TGCAAAGCCAATC-3’ with a primer concentration of 20 picomols, as per the method 
described by SAMBROOK and RUSSELL (2001). The expression proﬁ ling of p53 and 
cox-2 genes in mammary tumour affected male dogs was determined using Reverse 
Transcriptase PCR with gene speciﬁ c primers for p53, namely: F: 5’-GCGGCCCAT 
CCTCACTATC-3’ and R: 5’-CACAAACGCGTACCTCAAAGC-3’ and with gene 
speciﬁ c primer for cox-2 gene namely: F: 5’- ATGGGTGTGAAAGGCAAGAAA-3’ and 
R: 5’-GGTAAAGTGCTGGGCAAAGAAT-3’ with a primer concentration of 5 picomols 
for each gene. RPL was used as a house keeping gene (endogenous control) for the 
analysis of data. The total RNA was isolated from mammary tumours using Tri-reagent 
(Sigma, USA) as per the manufacturer’s instructions. Each DNase treated total RNA 
sample (1 μg) was reverse transcribed with a suitable negative and positive control, using 
the IScript DNA synthesis kit (BIORAD) according to the manufacturer’s instructions.
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Surgical therapy was performed in all animals after conﬁ rming the histological nature 
(benign) of the tumorous growth. The owner’s consent was also taken into consideration 
before surgical therapy. All the cases were under surveillance for six months post-surgery 
for any recurrence, if any, by regular telephone conversations with the pet owners.
The data pertaining to various parameters studied in canine cancer patients were 
analysed using the ‘paired-t’ test and analysis of variance (ANOVA) as per standard 
statistical methods.
Necessary permission was obtained from the Institute’s Animal Ethics Committee 
(IAEC) to conduct this research on clinical cases.
Results 
History revealed that these tumours developed vigorously within a very short period 
of time. Out of 7 animals, solitary tumours were seen in six animals (Fig. 1, 2), whereas 
multiple small tumours developed in one animal. The majority of tumours were well 
circumscribed and pedunculated except two, where ulcerated lesions were observed. 
Grossly, the mammary gland tumours were soft to ﬁ rm in consistency, tan to off-white 
in colour, pedunculated, sessile or subcutaneous masses that ranged from 6-9 cm at their 
largest dimension. Most of the mammary gland tumours were observed in the 4th (caudal 
abdominal) and 5th (inguinal) mammary glands. 
 
Lateral radiography of the thorax of the male dogs affected by mammary gland 
tumours revealed no radio-opaque, soft tissue scattered lesions in the lungs.
All the cases that underwent surgery had an uneventful recovery. The animals 
appeared quite alert and responsive throughout the postoperative period. Postoperative 
complications, such as herniation, stitch abscess, peritonitis etc. were not observed in any 
case. Complete wound healing was observed on the 12-15th day post-surgery. No sign of 
any recurrence was observed up to six months post-surgery.
Fig. 1. Mammary tumour in a male dog Fig. 2. Mammary tumour in another male dog
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Histologically, all but one tumour were diagnosed as simple adenoma. A simple 
adenoma is characterized by single or multiple well circumscribed nodules, composed 
of numerous acinar structures and papillary projections, lined by a single or multiple 
layers of cuboidal to columnar epithelium. The neoplastic cells were supported by a 
moderately thick ﬁ bro-vascular stroma. The majority of simple adenomas were arranged 
predominantly in an acinar pattern, with large areas of papillary growth. All mammary 
gland tumours have a continuous layer of spindle-shaped myoepithelial cells immediately 
subjacent to the epithelial layer lining acini and papillary projections (Fig. 3, 4). The single 
case of complex adenoma was characterized by acinar adenomatous growth, punctuated 
by several small islands of spindled myoepithelial cells, in a myxomatous matrix (Fig. 5).
The serum oestrogen value analysed in these male animals with mammary gland 
tumour was found very high. The level of estradiol was found to be 978 ± 26 pg/mL 
(mean ± SE) in dogs with mammary gland tumours. Similarly, serum progesterone value 
in male dogs with mammary gland tumours was also found high. The mean ± SE value 
of progesterone was found to be 2.16 ± 0.58 ng/mL verses the basal value of <1 ng/mL. 
 
Fig. 5. Complex adenoma
Fig. 3. Papillary adenoma Fig. 4. Papillary acinar adenoma
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Fig. 8. PCR ampliﬁ cation of MMP7 gene
Higher levels of p53 gene expressions were detected in 4 out of 7 (57.14%) animals 
when compared with normal mammary tissues. Mean p53 expression levels of mammary 
gland tumour and normal mammary tissue were 4.57 ± 1.44 and 1.00 ± 00, respectively. 
Higher levels of cox-2 gene expressions were also detected in 5 out of 7 (71.42%) cases, 
when compared with normal mammary tissues. Mean cox-2 expression levels of mammary 
gland tumour and normal mammary tissue were 6.25 ± 1.28 and 1.00 ± 00, respectively. 
Comparing the levels of expression of p53 and cox-2 gene in the male canine mammary 
gland tumours and the normal mammary tissue, there was a signiﬁ cant increase in the 
expression of p53 and cox-2 genes in tumour tissue (P<0.05). A relative gene expression 
level of p53 and cox-2 genes was recorded (Fig. 6, 7). For RT-PCR analysis of MMP-7 in 
male canine mammary tumour tissue, the total RNA from male canine mammary tumour 
Fig. 6. Relative gene expression of p53 gene. 
NCMT-normal canine mammary tissue; 
MCMTT-male canine mammary tumour tissue. 
Fig. 7. Relative gene expression of Cox-2 gene
543Vet. arhiv 84 (5), 537-548, 2014
S. K. Maiti et al.: Mammary tumours in male dogs
tissue was isolated. The ratio of A260/A280 was 1.9, indicating that the isolated RNA was 
reasonably free of contamination. The RT-PCR products were subjected to 1% agarose 
gel electrophoresis and the results are shown in Fig. 8. The concentration of amplicon 
appeared to be high in the tumour samples when compared with that of normal male dog 
samples. The male canine mammary gland tumour tissues also showed higher levels of 
expressions of MMP- 7 enzymes in comparison to normal male mammary tissue. 
Discussion
Mammary gland tumours are common in female dogs, accounting for up to 42% of 
all tumours in the bitch (DORN et al., 1968). Mammary gland tumours in male dogs are far 
less common, accounting for between 0 and 2.7% of all mammary gland tumours in dogs 
(MOULTON et al., 1970).The prevalence of mammary gland tumours in female dogs has 
been associated with age and breed (KHIMTA et al., 2010). The average age of onset for the 
tumours in male dogs in this study was 9.4 yrs. BEARSS et al. (2012) also reported that the 
average age of mammary gland tumours in male dog was 9.2 yrs. Like mammary gland 
tumours in female dogs, most of the mammary gland tumours in male dogs were observed 
in the 4th (caudal abdominal) and 5th (inguinal) mammary glands. The reason for this 
might be that the posterior glands have a greater volume of glandular tissue to react to any 
carcinogenic stimulus. The higher prevalence of mammary gland tumours in the caudal 
glands in male dogs is also attributed to the increased mass of mammary tissue in which a 
tumour might arise, although male mammary tissue is composed of only ductal elements 
and is devoid of fully developed terminal duct lobular units (BEARSS et al., 2012).
Radiography of the thorax provided information pertaining to the extent of organ 
involvement and the presence of metastasis in the lungs. Lateral radiography of the 
thorax in dogs affected by mammary gland tumours revealed no radio-opaque, soft tissue 
scattered lesions in the lungs, and thereby the involvement of pulmonary metastasis was 
ruled out in all cases subject to surgical treatment.
In this study, all tumours were removed by surgical excision. Surgery is the ﬁ rst choice 
for treatment of canine mammary gland tumours, in the absence of metastatic disease and 
inﬂ ammatory carcinoma (CASSALI et al., 2011; MAITI et al., 2011). The complete surgical 
removal of localized tumours without metastatic involvement is the therapeutic procedure 
with the highest probability of cure. Surgical excision of mammary gland tumours also 
allows histological examination, increases survival time, improves the patient’s quality of 
life, modiﬁ es disease progression and can be curative (CASSALI et al., 2011). 
Histologically, all but one tumour were diagnosed as simple adenomas. BEARSS et 
al. (2012) reported 27 mammary gland tumours in 18 male dogs and all tumours were 
histologically diagnosed as benign simple adenomas with mixed acinar and papillary 
pattern. SABA et al. (2007) also reported all benign mammary gland tumours in 8 male 
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dogs. This is in contrast to previous reports on mammary gland tumours in male dogs, 
in which 28 of 51 were classiﬁ ed as malignant (JABARA, 1969; MITCHELL et al., 1974).
All male dogs affected by mammary gland tumours showed a higher expression of 
oestrogen and progesterone concentrations. These ﬁ ndings correlated with the etiological 
factor in the occurrence of spontaneous canine mammary tumours in male dogs, which 
appears to be sex hormone dependent. Canine and human mammary gland tumours are 
hormone dependent, and both benign/malignant canine mammary gland tumours express 
the oestrogen receptor (ER) (SORENMO, 2003). Though ER as well as PR (the progestine 
receptor) is present in almost all histologically normal canine mammary tissues, ER 
expression remains high in benign tumours (RUTTEMAN et al., 1988) and it is signiﬁ cantly 
reduced in carcinomas in female dogs. PR expression also showed a progressive decrease 
from benign to malignant canine mammary lesions (MILLANTA et al., 2005). In this study, 
all the mammary tumours were benign and hence in agreement with these ﬁ ndings. It 
could be concluded that it is the presence of these female sex hormones, namely oestrogen 
and progesterone, that is promoting the growth of these tumours in male animals.
In this study, higher levels of p53, cox-2 and MMP-7 gene expressions were detected 
in the majority of cases. The presence of a p53 mutation is signiﬁ cantly associated with 
larger tumour diameter (FAILLE et al., 1994) and p53 mutation is used as a risk factor 
for increased risk of recurrence and death from breast cancer, independent of tumour 
size and hormone receptor levels (IACOPETTA et al., 1998). Over expression of the 
p53 gene in canine mammary gland tumours, in comparison to corresponding normal 
mammary gland tissue, was also reported by other authors (RUNGSIPIPAT et al., 1999; 
KUMARAGURUPURAM et al., 2005). The inactivation of the p53 gene, as a result of 
mutation, is a key step in neoplastic transformation and progression (VELDHOEN et al., 
1999). p53 gene protein over expression was found to be a useful predictor of increased 
malignant potential and poor prognosis in canine mammary gland tumours (LEE et al. 
2004). High expression of the cox-2 gene was detected in male mammary gland tumours, 
in comparison to normal mammary gland tissue. Over expression of cox-2 in human 
and canine mammary gland tumours was also reported by PRESCOTT and FITZPATRICK 
(2002). Cyclooxygenase-2 is a potential marker for mammary cancer in woman and dogs, 
as its expression is higher in tumours with poor prognosis. It inversely correlates with the 
overall survival rate, which changes the prognosis (LAVALLE et al., 2009). Enhanced cox-2 
expression is sufﬁ cient to induce mammary gland tumour genesis. Cox-2 over expression 
in canine mammary gland tumours was associated with a high tumour histological grade, 
greater tumour metastatic and recurrence rates, and shortened survival time (DORE et al., 
2003). 
In this study, a high expression of the MMP-7 (matrilysin) gene was detected in 
male mammary gland tumours, in comparison to normal mammary gland tissue. The 
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smallest member of the MMP family is MMP-7 (matrilysin), which is mainly expressed 
by epithelial cells. Matrilysin is one of the matrix metalloproteinase that has a critical 
role in tumour invasion, and it is often expressed in cancers (ADACHI et al., 1999). Like 
other MMPs, matrilysin can promote cancer invasion by proteolytic cleavage of the 
ECM substrates. Matrilysin activates other MMPs, such as proMMP-2 and proMMP-9, 
to facilitate tumour invasion. Matrilysin inﬂ uences the early stage of tumour genesis 
(NELSON et al., 2000). 
-The exact cause of mammary cancer in male dogs is still obscure. However, some 
previous reports of mammary neoplasia in male dogs implicated hormonal abnormalities, 
particularly in association with testicular neoplasm, as the cause of the tumours (JABARA, 
1969; RAFLO and DIAMOND, 1980). None of the dog in this study had testicular neoplasia 
or other testicular abnormalities. Some other risk factors for mammary tumours in males 
are undescended testis, orchiectomy, testicular injury or inﬂ ammation, hormonal therapy, 
high blood cholesterol, rapid weight gain, obesity and diabetes (THOMAS et al., 1992). 
However, in this study, there was no history of obesity, diabetes or sex hormone therapy 
in any affected animal.
In summary, mammary neoplasia in male dogs is rare. In this study, middle-aged, 
intact male dogs of pure as well as mixed breed were affected. Almost all tumours were 
simple adenomas and histologically benign, without any evidence of recurrence or 
metastasis. Various tumour marker genes, which include p53, cox-2 and MMP-7, showed 
higher expressions as compared to normal male dogs. Expression of sex hormones in 
these male dogs was signiﬁ cantly higher. All tumours were excised surgically and healed 
uneventfully. However, a larger number of cases is required to study conclusively the 
possible role of hormones and the correlation between castration and the incidence of 
male mammary gland tumours.
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SAŽETAK
U istraživanje je bilo uključeno sedam pasa s potvrđenim tumorima mliječne žlijezde, koji nikada 
nisu opasivali kuje. Njihova prosječna dob kod postavljanja dijagnoze iznosila je 9,4 godina. Pet ih je bilo 
čistokrvnih, a dva mješanca. U šest je pasa bio ustanovljen solitarni, a u jednoga multipli rast. Svi su histološki 
bili dobroćudni. Ustanovljeni su adenomi s miješanim acinarnim i papilarnim oblikom. Svi su bili kirurški 
uklonjeni. Ozdravljenje je bilo potpuno bez ikakvih postoperativnih komplikacija. Tumori se nisu povratno 
javili šest mjeseci nakon operacije. U većini slučajeva bila je izražena aktivnost šest hormona i tumorskih 
biljega p53, cox-2 i MMP-7. Iako rijetko, tumori mliječne žlijezde javljaju se i u pasa. 
Ključne riječi: pas, mužjak, tumor mliječne žlijezde, kirurgija, tumorski biljezi________________________________________________________________________________________
